SCHEMBL7860970

SCHEMBL7860970

Nc1ccc(CCOC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1I

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.57
P2RY1 P47900 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
P2RY2 P41231 3/20 0.57
SRC P12931 2/20 0.57
DNPH1 O43598 1/20 0.57
PRKAB2 O43741 1/20 0.57
TRPM2 O94759 1/20 0.57
LDHA P00338 1/20 0.57
ADRB2 P07550 1/20 0.57
FBP1 P09467 1/20 0.57
PRKAG1 P54619 1/20 0.57
PRKAA2 P54646 1/20 0.57
PDE4D Q08499 1/20 0.57
KCNH2 Q12809 1/20 0.57
PRKAA1 Q13131 1/20 0.57
PDE3A Q14432 1/20 0.57
TAS1R3 Q7RTX0 1/20 0.57
TAS1R1 Q7RTX1 1/20 0.57
P2RY11 Q96G91 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8664327 0.91 ADORA1 (0.58) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL13269023 0.88 ADORA1 (0.58) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL447210 0.87 ADORA1 (0.62) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL1434130 0.86 ADORA1 (0.67) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL8328542 0.84 ADORA1 (0.74) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL13268940 0.84 ADORA2A (0.57) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL13269099 0.84 ADORA2A (0.57) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL2270709 0.81 ADORA1 (0.73) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL6828798 0.81 ADORA1 (0.70) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL2534140 0.80 EHMT1 (0.70) ADORA1P2RY1SMN1; SMN2P2RY2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303619-B1 BLOCKING VASOCONSTRICTIVE RESPONSE INDUCED THROUGH ADENOSINE ACTIVATION OF THE A.SUB.3 ADENOSINE RECEPTOR SUBTYPE, COMPRISING ADMINISTERING XANTHINE DERIVATIVE TO MAMMAL UNIVERSITY OF VIRGINIA 2001-10-16 US disclosed
US-5817760-A MAMMALIAN CELL MEMBRANES MERCK & CO., INC. (US) 1998-10-06 US disclosed
EP-0689405-A4 METHODS FOR PROTECTING TISSUES AND ORGANS FROM ISCHEMIC DAMAGE GENSIA INC (US) 1996-09-11 EP disclosed
EP-0689405-A1 METHODS FOR PROTECTING TISSUES AND ORGANS FROM ISCHEMIC DAMAGE GENSIA, INC. (US) 1996-01-03 EP disclosed
WO-1995011681-A1 HUMAN ADENOSINE RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1995-05-04 WO disclosed
WO-1994021195-A1 METHODS FOR PROTECTING TISSUES AND ORGANS FROM ISCHEMIC DAMAGE GENSIA, INC. (US) 1994-09-29 WO disclosed